4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-22-021390
Chief Financial Officer sold 13,286 shares at $30.00 ($398,580)
- Chief Financial Officer acquired 13,286 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Catinazzo Thomas Chief Financial Officer | 2022-03-24 | Option exercise | +13,286 | $4.12 | $54,738 | 67,545 | D: show line 1 in the form |
| Catinazzo Thomas Chief Financial Officer | 2022-03-24 | Sale | −13,286 | $30.00 | $398,580 | 54,259 | D: show line 2 in the form |
| Open-market sales · 13,286 sh · avg $30.00 · $398,580 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Catinazzo Thomas Chief Financial Officer | 2022-03-24 | Option exercise · Stock Option (Right to Buy) | −13,286 | 26,257 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…